Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Quality Assessment of Reporting Performance for EGFR Molecular Diagnosis in Non-Small Cell Lung Cancer.

The oncologist - 1 Nov 2017

Han Yanxi, Zhang Rui, Lin Guigao, Zhang Kuo, Xie Jiehong, Li Jinming

Abstract excerpt

BACKGROUND: Reports serve as a bridge between laboratories and clinicians, help synthesize an overwhelming amount of raw data into evidence-based medicine, and play a significant role in designing clinical treatments. In an effort to guarantee high-quality epidermal growth factor receptor (EGFR) gene mutation testing and reporting performance, the National Center for Clinical Laboratories launched a proficiency...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to China
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to EGFR gene

Share to Mutation

Share to Pathology, Molecular

Share to Quality Assurance, Health Care

Source

Open in PubMed Open full text

Identifiers

PMID: 28701573
DOI: 10.1634/theoncologist.2017-0042
PMCID: PMC5679822

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Quality Assessment of Reporting Performance for EGFR Molecular Diagnosis in Non-Small Cell Lung Cancer.PMID 28701573Read ↗

Molecular Pathology Testing for Non-small Cell Lung Cancer: An Observational Study of Elements Currently Present in Request Forms and Result Reports and The Opinion of Different StakeholdersSemantic proximity Read ↗

Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing.Semantic proximity Read ↗

Reporting Results of Molecular Tests: A Retrospective Examination of BRAF Mutation Reporting.Semantic proximity Read ↗

What's in a Name? A Coordinated Approach toward the Correct Use of a Uniform Nomenclature to Improve Patient Reports and Databases.Semantic proximity Read ↗

Template for reporting results of biomarker testing of specimens from patients with non-small cell carcinoma of the lung.Semantic proximity Read ↗

Improvement in the quality of molecular analysis of EGFR in non-small-cell lung cancer detected by three rounds of external quality assessment.Semantic proximity Read ↗

NSCLC molecular testing in Central and Eastern European countries.Semantic proximity Read ↗

Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe.Semantic proximity Read ↗

Results of the First Italian External Quality Assurance Scheme for somatic EGFR mutation testing in non-small-cell lung cancer.Semantic proximity Read ↗

Results of a worldwide External Quality Assessment of cfDNA testing in Lung CancerSemantic proximity Read ↗

Results of a worldwide external quality assessment of cfDNA testing in lung Cancer.Semantic proximity Read ↗

EGFR and KRAS quality assurance schemes in pathology: generating normative data for molecular predictive marker analysis in targeted therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.